Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Vaginitis Treatment Drugs Market - Global Industry Analysis and Opportunity Assessment, 2020-2030


News provided by

Reportlinker

Aug 31, 2020, 15:00 ET

Share this article

Share toX

Share this article

Share toX

NEW YORK, Aug. 31, 2020 /PRNewswire/ -- A recent market study published on the Vaginitis Treatment Drugs Market including global industry analysis for 2015-2019 & opportunity assessment for 2020-2030, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the Vaginitis Treatment Drugs Market, growth prospects are obtained with maximum precision.

Read the full report: https://www.reportlinker.com/p05953997/?utm_source=PRN

Vaginitis Treatment Drugs Market: Segmentation
The global vaginitis treatment is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Drug Type
Nitroimidazole Compound
Lincosamide Antibiotics
Triazoles
Imidazoles
Indication

Bacterial Vaginitis
Fungal Vaginitis (Yeast Infection)
Trichomoniasis
Route of Administration

Oral
Cutaneous
Vaginal
Route of Administration

Oral
Cutaneous
Vaginal
Schedule of Drug

Prescription Drugs (Rx)
Over-the-counter Drugs (OTC)

Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Mail Order Pharmacies
Regions

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa (MEA)

Report Chapters

Chapter 01 – Executive Summary

The report initiates with the executive summary of the Vaginitis Treatment Drugs Market , which includes a summary of key findings and statistics of the market. It also includes market size and revenue distribution of market segment of the Vaginitis Treatment Drugs Market .

Chapter 02 – Market Overview

Readers can find the definition and a detailed segmentation of the Vaginitis Treatment Drugs Market in this chapter, which will help them understand the basic information about the market.

Chapter 03 – Key Market Trends

This section includes key product development trend and innovative market expansion strategies.

Chapter 04 – Market Context

This section includes premium insights such as regulatory scenario, epidemiology analysis, pipeline analysis, reimbursement scenario and many more. This section helps readers understand the key factors associated with the Vaginitis Treatment Drugs Market .

Chapter 05 – Market Background

This chapter explains the key macroeconomic factors, drivers, restraints, trends and opportunity analysis that are expected to influence growth of the Vaginitis Treatment Drugs Market over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section. This chapter also covered the COVID19 Crisis impact analysis on vaginitis treatment drugs sales.

Chapter 06 –Global Vaginitis Treatment Drugs Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020–2030

This section explains the global market value analysis and forecast for the vaginitis treatment during the forecast period. This chapter includes a detailed analysis of the historical Vaginitis Treatment Drugs Market , along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2020), and an incremental $ opportunity for the forecast period (2020–2030).

Chapter 07 – Global Vaginitis Treatment Analysis 2015-2019 & Opportunity Assessment 2020-2030, by Drug Type

Based on drug type, the Vaginitis Treatment Drugs Market is segmented nitroimidazole compound, lincosamide antibiotics, triazoles and imidazoles. In this chapter, readers can find information about the key trends and developments in vaginitis treatment and market attractiveness analysis based on drug type.

Chapter 08 – Global Vaginitis Treatment Analysis 2015-2019 & Opportunity Assessment 2020-2030, by Indication

This chapter provides details about the vaginitis treatment based on indication, and has been classified into bacterial vaginitis, fungal vaginitis (yeast infection) and trichomoniasis. In this chapter, readers can understand the market attractiveness analysis based on indication.

Chapter 09 – Global Vaginitis Treatment Analysis 2015-2019 & Opportunity Assessment 2020-2030, by Route of Administration

This chapter provides details about the Vaginitis Treatment Drugs Market based on route of administration, and has been classified into oral, cutaneous and vaginal. In this chapter, readers can understand the market attractiveness analysis based on route of administration.

Chapter 10 – Global Vaginitis Treatment Analysis 2015-2019 & Opportunity Assessment 2020-2030, by Schedule of Drug

This chapter provides details about the Vaginitis Treatment Drugs Market based on schedule of drug, and has been classified into prescription drugs (Rx) and over-the-counter drugs (OTC). In this chapter, readers can understand the market attractiveness analysis based on schedule of drug.

Chapter 11 – Global Vaginitis Treatment Analysis 2015-2019 & Opportunity Assessment 2020-2030, by Distribution Channel

This chapter provides details about the vaginitis treatment based on distribution channel, and has been classified into hospital pharmacies, retail pharmacies, drug stores, and mail order pharmacies. In this chapter, readers can understand the market attractiveness analysis based on distribution channel.

Chapter 12 – Global Vaginitis Treatment Analysis 2015-2019 & Opportunity Assessment 2020-2030, by Region

This chapter explains how the Vaginitis Treatment Drugs Market will grow across various geographic regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa (MEA).

Chapter 13 – North America Vaginitis Treatment Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter includes a detailed analysis of growth of the North America Vaginitis Treatment Drugs Market , along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, and market growth based on the drug type and countries in North America.

Chapter 14 – Latin America Vaginitis Treatment Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter provides the growth scenario of the Vaginitis Treatment Drugs Market in Latin American countries such as Argentina, Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.

Chapter 15 –Europe Vaginitis Treatment Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter provides the growth scenario of the Vaginitis Treatment Drugs Market in Europe in several countries such as Germany, the U.K., France, Spain, Italy, Russia and the Rest of Europe are included in this chapter.

Chapter 16 – South Asia Vaginitis Treatment Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter provides the growth scenario of the Vaginitis Treatment Drugs Market in South Asia in several countries such as India, Thailand, Malaysia, Indonesia, Rest of South Asia are included in this chapter.

Chapter 17 – East Asia Vaginitis Treatment Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter highlights the growth of the vaginitis treatment in East Asia by focusing on China, South Korea, and Japan. This section also help readers understand the key factors that are responsible for the growth of the Vaginitis Treatment Drugs Market in East Asia.

Chapter 18 – Oceania Vaginitis Treatment Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter highlights the growth of the vaginitis treatment in Oceania. This section also help readers understand the key factors that are responsible for the growth of the Vaginitis Treatment Drugs Market in Australia and New Zealand.

Chapter 19 – Middle East & Africa Vaginitis Treatment Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter provides information about how the Vaginitis Treatment Drugs Market will grow in major countries in the Middle East & Africa region such as GCC Countries, South Africa, Turkey, Northern Africa and the Rest of MEA, during the forecast period.

Chapter 20 – Key and Emerging Countries Vaginitis Treatment Drugs Market Analysis

This chapter provides information about how the Vaginitis Treatment Drugs Market will grow in key and emerging countries such as the U.S., Canada, Germany, U.K, France, Italy, China, India, Japan, South Korea, South Africa, Turkey and other countries during the forecast period.

Chapter 21- Market Structure Analysis

In this chapter, readers can find detailed company share analysis, and tier structure analysis.

Chapter 22 – Competition Analysis

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the Vaginitis Treatment Drugs Market , along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Pfizer Inc., Mylan NV, Novartis AS, Bayer AG and more.

Chapter 23 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the vaginitis treatment report.

Chapter 24 – Research Methodology
This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the Vaginitis Treatment Drugs Market .

Read the full report: https://www.reportlinker.com/p05953997/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]  
US: (339)-368-6001
Intl: +1-339-368-6001

SOURCE Reportlinker

Related Links

www.reportlinker.com

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.